Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisak

Showing results (501-510 of 529) with videos related to

Pageof 53
Sort By:
Plos One|April 9, 2019
Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virusAndrey L Matveev, Irina V Kozlova, Oleg V Stronin, et al.
Voprosy Virusologii|December 10, 2022
DEFINITION AND COMPARATIVE ANALYSIS OF THE GENOMIC STRUCTURE OF SIBERIAN STRAINS OF TICK-BORNE ENCEPHALITIS VIRUS OF THE EUROPEAN SUBTYPET V Demina, I V Kozlova, S E Tkachev, et al.
Plos One|October 12, 2016
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal FluidDeepak K Kaushik, Heather Y F Yong, Jennifer N Hahn, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; MalignancyAzra Raza, Huma Qawi, Tanja Andric, et al.
Annals of Medicine|May 12, 2026
Assay-dependent variability in peptide biomarker quantification: experimental evidence from renalase in chronic kidney diseaseNatalia Serwin, Elżbieta Cecerska-Heryć, Bartłomiej Grygorcewicz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2022
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension studyCorey C Ford, Jeffrey A Cohen, Andrew D Goodman, et al.
Neurology|April 1, 1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, J A Cohen, et al.
Ticks and Tick-Borne Diseases|March 25, 2017
Comparative analysis of complete genome sequences of European subtype tick-borne encephalitis virus strains isolated from Ixodes persulcatus ticks, long-tailed ground squirrel (Spermophilus undulatus), and human blood in the Asian part of RussiaT V Demina, S E Tkachev, I V Kozlova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference ProceedingsCarolyn Goldschmidt, Steven L Galetta, Robert P Lisak, et al.
Ebiomedicine|September 13, 2023
Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosisHanane Touil, Rui Li, Leah Zuroff, et al.
Pageof 53

Showing results (501-510 of 529) with videos related to

Sort By:
Pageof 53
Plos One|April 9, 2019
Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virusAndrey L Matveev, Irina V Kozlova, Oleg V Stronin, et al.
Voprosy Virusologii|December 10, 2022
DEFINITION AND COMPARATIVE ANALYSIS OF THE GENOMIC STRUCTURE OF SIBERIAN STRAINS OF TICK-BORNE ENCEPHALITIS VIRUS OF THE EUROPEAN SUBTYPET V Demina, I V Kozlova, S E Tkachev, et al.
Plos One|October 12, 2016
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal FluidDeepak K Kaushik, Heather Y F Yong, Jennifer N Hahn, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; MalignancyAzra Raza, Huma Qawi, Tanja Andric, et al.
Annals of Medicine|May 12, 2026
Assay-dependent variability in peptide biomarker quantification: experimental evidence from renalase in chronic kidney diseaseNatalia Serwin, Elżbieta Cecerska-Heryć, Bartłomiej Grygorcewicz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2022
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension studyCorey C Ford, Jeffrey A Cohen, Andrew D Goodman, et al.
Neurology|April 1, 1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, J A Cohen, et al.
Ticks and Tick-Borne Diseases|March 25, 2017
Comparative analysis of complete genome sequences of European subtype tick-borne encephalitis virus strains isolated from Ixodes persulcatus ticks, long-tailed ground squirrel (Spermophilus undulatus), and human blood in the Asian part of RussiaT V Demina, S E Tkachev, I V Kozlova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference ProceedingsCarolyn Goldschmidt, Steven L Galetta, Robert P Lisak, et al.
Ebiomedicine|September 13, 2023
Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosisHanane Touil, Rui Li, Leah Zuroff, et al.
Pageof 53